Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
265 GBX | +6.00% | +23.26% | -13.11% |
11:18am | Faron Pharmaceuticals’ Blood Cancer Combo Shows Efficacy in Mid-stage Study | MT |
10:04am | Faron Pharma celebrates positive read-out in ongoing MDS trial | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.11% | 23Cr | |
+9.58% | 11TCr | |
+12.41% | 11TCr | |
-2.59% | 2.2TCr | |
-12.38% | 2.19TCr | |
-5.29% | 1.92TCr | |
-3.35% | 1.81TCr | |
-38.57% | 1.77TCr | |
+7.51% | 1.43TCr | |
+35.67% | 1.24TCr |
- Stock Market
- Equities
- FARN Stock
- News Faron Pharmaceuticals Oy
- Faron Pharmaceuticals Chief Medical Officer Steps Down, Interim Successor Named